Industry Research Reports and Market Analysis at MindBranch.com Research Index | Publishers | My Account | Contact Us | About MindBranch
Welcome Guest  (Login/Register) |  0 items
  
Advanced Search > | Tips >
Contact a
Research Assistant

US 800-774-4410
or +1-240-747-3094

Search Assistance >

Home  > Healthcare  >  Pharmaceutical  >  Drug Discovery

Optimizing PLM Technology for the Pharmaceutical Industry (Technology Focus)


Published Date: July 2007
Published By: Datamonitor
Page Count: 13
Order Code: R313-23918
 
DescriptionTable of ContentsSearch Inside
this Report
Similar
Products

Introduction

Datamonitor views product lifecycle management (PLM) technology as one of the most rapidly growing market in the pharmaceutical industry due to its inherent focus on time to market and product development, key business priorities in this market.

Scope

  • PLM software and services
  • Geographic coverage includes North America, Western Europe and APAC
  • Pharmaceutical sectors cover Big Pharma and Biotech


  • Highlights

    Pharmaceutical product lifecycle management technology is gaining momentum

    PLM technology should align to the pharmaceutical industry's business challenges

    Six technology features reflect how PLM technology is aligned to the industry

    Reasons to Purchase

  • Understand how PLM technology aligns to the pharmaceutical industry pain points
  • Learn the six technology attributes that make PLM attractive to Big Pharma and Biotech companies

  • Similar Products
    Latin American Rheumatoid Arthritis Drugs Market
    Published Oct 2008 by Frost & Sullivan


    Pipeline and Commercial Insight: Schizophrenia - Second generation depots protect market value
    Published Oct 2008 by Datamonitor


    Currently Druggable in Melanoma:A Drug Target Competitive Analysis
    Published Oct 2008 by BioSeeker Group AB


    Plunkett's Health Care Technologies Overview 2009 (Summary)
    Published Oct 2008 by Plunkett Research, Ltd.


    Global Antivirals Market Analysis & Forecasts 2008-2023
    Published Oct 2008 by Visiongain


    Stakeholder Insight: Osteoporosis - Generic alendronate further establishes oral bisphosphonates as gold standard
    Published Oct 2008 by Datamonitor


    Outsourcing in Drug Development: The Contract CRO Market, 3rd Edition
    Published Oct 2008 by Kalorama Information


    GPCRs: Dawn of a New Era?
    Published Oct 2008 by CHI Insight Pharma Reports


    Protein Drugs: Global Markets and Manufacturing Technologies
    Published Oct 2008 by BCC Research


    China's Pharmaceutical Industry - Porter’s Five Forces Strategy Analysis
    Published Oct 2008 by Aruvian Research




     


    Privacy Policy | Terms & Conditions | Site Map | Return Policy | Help FAQs
    Copyright © 1999-2008, All Rights Reserved, MindBranch.com
    Trust-e Logo
    Phone: 800-774-4410 (US) or +1-240-747-3094 (Int'l)
    Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
    Email: support@mindbranch.com